Reclassification of substances

A more refined distinction is required to define appropriate drug control measures according to the specific characteristics of substances, their health risks, the dynamics of their markets and their user groups. The classification schedules of the UN 1961 and 1971 Conventions do not provide sufficient differentiation. The consideration of such diverse substances as coca, cocaine, cannabis, opium and heroin in the same schedule, hampers effective policy responses taking account of the different properties and reasons people use them.

  • The concept of ‘drug harms’

    Peter Cohen
    Drugs and Alcohol Today
    December 2010

    publicationIn my view, perceived harms associated with drugs are vulnerable to so many restrictions on reliability and validity that, for the time being, a serious estimate of drug harm per drug is impossible. In my view, it is even invalid to associate harms to drugs alone. Drugs are used by humans, under individual, social and legal conditions, in certain purities and dosages. Whatever the 'effects' of drugs, harmful or not, they cannot be estimated or even discussed without associating the drug with a particular user or user culture. Drugs per se do not meaningfully exist.

    application-pdfDownload the document (PDF)

    Read more...
  • Drug harms in the UK

    A multicriteria decision analysis
    David J Nutt, Leslie A King, Lawrence D Phillips, on behalf of the Independent Scientific Committee on Drugs
    The Lancet
    November 1, 2010

    lancet-scheduling To provide better guidance to policy makers in health, policing, and social care, the harms that drugs cause need to be properly assessed. This task is not easy because of the wide range of ways in which drugs can cause harm. This study undertook a review of drug harms with the multicriteria decision analysis (MCDA) approach. This technology has been used successfully to lend support to decision makers facing complex issues characterised by many, conflicting objectives.

    application-pdfDownload the document (PDF)

    Read more...
  • Politics and science in classifying the dangers of drugs

    Robin Room & Dan I. Lubman
    Evidence Based Mental Health
    November 2010

    ebmh-11-2010There is a long history of psychoactive substances being regarded as dangerous and subsequently being banned or forbidden. Often the bans were introduced on substances new and unfamiliar to a society, which were viewed as more dangerous than substances which were well known and enculturated. With industrialisation and the globalisation brought by European empires, the growing availability of psychoactive substances was increasingly seen as a problem in the 1800s, setting off social and policy reactions – what we know as the temperance movement against alcohol,
    and initial UK legislation limiting the sale of ‘poisons’.

    application-pdfDownload the article (PDF)

    Read more...
  • Guidance on the WHO review of psychoactive substances for international control

    WHO EB126/21
    December 17, 2009

    who-guidanceThe 1961 UN Single Convention on Narcotic Drugs and the 1971 Convention on Psychotropic Substances, entrust the Expert Committee on Drug Dependence of the World Health Organization (WHO) with the responsibility of assessing substances for abuse liability in order to make recommendations on their control under the two aforementioned Conventions.

    application-pdfDownload the document (PDF)

    Read more...
  • TNI Expert Seminar on the Classification of Controlled Substances

    Transnational Institute
    Amsterdam
    December 10, 2009

    expert-seminarThe classification of drugs has a profound impact on the lives and well-being of individuals across the world and where the classification is incorrect, people suffer unnecessarily. This is an issue that deserves greater public awareness and greater engagement with citizenry and that where such public awareness is in place it should be galvanised in order to work towards a new democratic answer to this difficult situation.

    application-pdfDownload the report (PDF)

    Read more...
  • Estimating drug harms: a risky business?

    David Nutt
    Centre for Crime and Justice Studies Briefing 10
    October 2009

    estimatingNo one is suggesting that drugs are not harmful. The critical question is one of scale and degree. We need a full and open discussion of the evidence and a mature debate about what the drug laws are for - and whether they doing their job? In `Estimating drug harms: a risky business', Professor David Nutt, of Imperial College London argues that the relative harms of legal drugs such as alcohol and tobacco are greater than those of a number of illegal drugs, including cannabis, LSD and ecstasy.

    application-pdfDownload the document (PDF)

    Read more...
  • Ranking van drugs

    Een vergelijking van de schadelijkheid van drugs
    J.G.C. van Amsterdam, A. Opperhuizen, M.W.J. Koeter, L.A.G.J.M. van Aerts & W. van den Brink
    Rijksinstituut voor Volksgezondheid en Milieu (RIVM)
    2009

    rankingIn its report Ranking of drugs: A comparison of the harmful effects of drugs, the National Institute for Public Health and the Environment (RIVM) has performed a risk assessment on the harmful effects of 17 drugs plus that of tobacco and alcohol. These 19 items were ranked according to their degree of harm.

    application-pdfDownload the report (only available in Dutch)

    Read more...
  • Risk assessment of new psychoactive substances

    Operating guidelines
    European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)
    2009

    risk-assessmentThe principal aim of these guidelines is to put in place a sound methodological and procedural basis for carrying out each risk assessment. The risk assessment has regard to the health and social risks of the use of, manufacture of, and traffic in the new psychoactive substance, the involvement of organised crime and the possible consequences of control measures. The guidelines were finalised and adopted by the EMCDDA’s Scientific Committee in November 2008.

    application-pdfDownload the document

  • Risk assessment of khat use in the Netherlands

    A review based on adverse health effects, prevalence, criminal involvement and public order
    E.J.M. Pennings, A. Opperhuizen & J.G.C. van Amsterdam
    Regulatory Toxicology and Pharmacology 52 (2008) 199–207
    August 2008

    In preparing a decision about the legal status of khat in the Netherlands, the Dutch Minister of Health requested CAM (Coordination point Assessment and Monitoring new drugs) to assess the overall risk of khat in the Netherlands. The present paper is a redraft of a report which formed the scientific basis of the risk evaluation procedure (October 2007). This report reviews the scientific data about khat available in the international literature. In addition, the report contains some information specific for the Netherlands (prevalence, availability of khat and public order aspects).

    application-pdfDownload the publication (PDF)

    Read more...
  • Cannabis: Classification and Public Health

    Advisory Council on the Misuse of Drugs
    April 2008

    amcd-cannabisThe Advisory Council on the Misuse of Drugs reviewed the classification of cannabis in the light of real public concern about the potential mental health effects of cannabis use and, in particular, the use of stronger strains of the drug.

    application-pdfDownload the document (PDF)

    Read more...

Page 1 of 2

Publications

goto
Legislative Innovation in Drug Policy

Good practices in legislative reforms around the world

Read more...

Tags

show

This website

support-ec-osi-disclaimer-web

Other projects

UN Drug Control

In 2011 the 1961 UN Single Convention on drugs will be in place for 50 years. In 2012 the international drug control system will exist 100 years since the International Opium Convention was signed in 1912 in The Hague. Does it still serve its purpose or is a reform of the UN Drug Conventions needed? This site provides critical background.

TNI/WOLA Drug Law Reform Project

Drug Law Reform in Latin America is a joint project of TNI and the Washington Office on Latin America (WOLA) tni_wola2
"Promoting a more effective and humane drug policy in Latin America"